HYOPZIG Trademark
HYOPZIG is a USPTO trademark filed by Bristol-Myers Squibb Company. Status: Pending.
Trademark Facts
| Mark | HYOPZIG |
|---|---|
| Serial Number | 97566236 |
| Status | Pending |
| Filing Date | 2022-08-26 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Bristol-Myers Squibb Company |
Goods & Services
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and ski